Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride. Mosapride is a gastroprokinetic agent that enhances upper GI motility by activating serotonin receptor 4 (5-HT4; EC50 = 74.2 nM, in guinea pig ileal longitudinal muscle myenteric plexus).1,2 Mosapride increases canine, equine, and guinea pig colonic motility in vivo.3,4 Formulations containing mosapride are used in human and veterinary medicine to prevent post-surgical- and Parkinson's-induced constipation.4,5.
WARNING This product is not for human or veterinary use.
1. Comparison of effect of mosapride citrate and existing 5-
2. Mosapride citrate (AS-
3. AS-
4. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility. Res. Vet. Sci. 86(2):, 302-308 (2009).
5. Mosapride citrate, a novel 5-